ShangPharma Corporation (NYSE: SHP) (“ShangPharma” or the “Company”), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will present at J.P. Morgan’s 30th Annual Healthcare Conference, to be held in San Francisco from January 9-12, 2012.
Mr. Michael Xin Hui, founder and Chief Executive Officer of ShangPharma, and Mr. William Dai, Chief Financial Officer, will present at the conference.
Presentation materials will be available under the Webcasts & Presentations section of the Company’s investor relations website at http://ir.shangpharma.com.
ABOUT SHANGPHARMA CORPORATION
ShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma’s services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.
CONTACT: 888-288-5215 · Please read our Full Disclaimer pertaining to this article.